Aemetis, Inc (NASDAQ:AMTX) Short Interest Down 15.3% in March

Aemetis, Inc (NASDAQ:AMTX) was the recipient of a significant decrease in short interest in the month of March. As of March 13th, there was short interest totaling 4,691,245 shares, a decrease of 15.3% from the February 26th total of 5,537,109 shares. Based on an average daily volume of 1,305,036 shares, the days-to-cover ratio is currently 3.6 days. Approximately 8.4% of the company’s shares are sold short.

Wall Street Analyst Weigh In

AMTX has been the subject of several research reports. Wall Street Zen upgraded shares of Aemetis from a “sell” rating to a “hold” rating in a research report on Sunday, March 22nd. Loop Capital set a $1.75 target price on Aemetis in a research report on Thursday, March 12th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, January 21st. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Aemetis has an average rating of “Hold” and a consensus target price of $8.25.

Aemetis Stock Down 1.8%

AMTX stock opened at $3.13 on Wednesday. The stock’s 50 day moving average is $1.87 and its two-hundred day moving average is $1.94. The company has a market capitalization of $208.75 million, a PE ratio of -2.36 and a beta of 2.61. Aemetis has a 52-week low of $1.22 and a 52-week high of $3.66.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings data on Thursday, March 12th. The specialty chemicals company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.04. The company had revenue of $43.31 million during the quarter, compared to the consensus estimate of $72.07 million. As a group, sell-side analysts anticipate that Aemetis will post -2.07 EPS for the current year.

Hedge Funds Weigh In On Aemetis

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Marshall Wace LLP increased its position in shares of Aemetis by 289.3% during the 4th quarter. Marshall Wace LLP now owns 559,754 shares of the specialty chemicals company’s stock worth $778,000 after purchasing an additional 415,978 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Aemetis by 15.3% in the 3rd quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company’s stock valued at $5,578,000 after buying an additional 329,760 shares in the last quarter. Jane Street Group LLC acquired a new stake in Aemetis during the 2nd quarter worth $634,000. CIBC Bancorp USA Inc. bought a new position in Aemetis during the third quarter worth about $563,000. Finally, 683 Capital Management LLC bought a new position in Aemetis during the fourth quarter worth about $327,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.